Armata Pharmaceuticals, Inc. (ARMP)
2.98
-0.19
(-5.99%)
USD |
NYAM |
Nov 19, 16:00
Armata Pharmaceuticals Cash from Investing (Quarterly) : -0.091M for Sept. 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -0.091M |
| June 30, 2026 | -0.017M |
| March 31, 2026 | -0.063M |
| December 31, 2025 | -0.052M |
| September 30, 2025 | -0.242M |
| June 30, 2025 | -0.149M |
| March 31, 2025 | -0.099M |
| December 31, 2024 | 0.077M |
| September 30, 2024 | -0.34M |
| June 30, 2024 | -1.366M |
| March 31, 2024 | -0.25M |
| December 31, 2023 | -2.39M |
| September 30, 2023 | -3.512M |
| June 30, 2023 | -0.222M |
| March 31, 2023 | -2.01M |
| December 31, 2022 | 0.455M |
| September 30, 2022 | -1.294M |
| June 30, 2022 | -1.136M |
| March 31, 2022 | -0.236M |
| December 31, 2021 | -0.228M |
| September 30, 2021 | -0.582M |
| June 30, 2021 | -0.196M |
| March 31, 2021 | -0.298M |
| December 31, 2020 | -0.366M |
| September 30, 2020 | -0.081M |
| Date | Value |
|---|---|
| June 30, 2020 | -0.273M |
| March 31, 2020 | -0.104M |
| December 31, 2019 | 0.072M |
| September 30, 2019 | 0.065M |
| June 30, 2019 | 2.882M |
| March 31, 2019 | -0.142M |
| December 31, 2018 | -0.535M |
| September 30, 2018 | -0.011M |
| June 30, 2018 | 9.36M |
| March 31, 2018 | 0.00 |
| December 31, 2017 | -0.018M |
| September 30, 2017 | -0.033M |
| June 30, 2017 | -0.002M |
| March 31, 2017 | -0.005M |
| December 31, 2016 | -0.013M |
| September 30, 2016 | -0.029M |
| June 30, 2016 | -0.125M |
| March 31, 2016 | -0.112M |
| December 31, 2015 | -0.05M |
| September 30, 2015 | -0.116M |
| June 30, 2015 | -0.009M |
| March 31, 2015 | -0.035M |
| December 31, 2014 | -0.005M |
| September 30, 2014 | -0.137M |
| June 30, 2014 | -0.831M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Lineage Cell Therapeutics, Inc. | -5.147M |
| Voyager Therapeutics, Inc. | 29.27M |
| Black Diamond Therapeutics, Inc. | 4.218M |
| Invivyd, Inc. | -0.585M |
| Elicio Therapeutics, Inc. | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -5.516M |
| Cash from Financing (Quarterly) | -0.028M |
| Free Cash Flow | -26.86M |
| Free Cash Flow Per Share (Quarterly) | -0.0895 |
| Free Cash Flow to Equity (Quarterly) | 56.76M |
| Free Cash Flow to Firm (Quarterly) | 1.954M |
| Free Cash Flow Yield | -24.24% |